- Investing Ideas
- U.S. Pharmaceuticals & Biotech Sustainable Track Record
U.S. Pharmaceuticals & Biotech Sustainable Track Record
Results
14
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
14 companies
Incyte
Market Cap: US$24.4b
A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.
INCY
US$123.50
7D
1.6%
1Y
45.4%
ACADIA Pharmaceuticals
Market Cap: US$4.9b
A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.
ACAD
US$29.01
7D
-1.3%
1Y
15.8%
Exelixis
Market Cap: US$12.7b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$52.32
7D
-1.2%
1Y
38.6%
CareDx
Market Cap: US$2.3b
Provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally.
CDNA
US$46.38
7D
-1.5%
1Y
291.4%
CorMedix
Market Cap: US$587.7m
A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
CRMD
US$7.67
7D
1.9%
1Y
-41.5%
Eli Lilly
Market Cap: US$1.1t
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.
LLY
US$1,183.16
7D
-4.0%
1Y
69.5%
Protalix BioTherapeutics
Market Cap: US$178.9m
A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.
PLX
US$2.29
7D
-7.7%
1Y
48.7%
Earth Science Tech
Market Cap: US$25.9m
Together with its subsidies, focuses on health and wellness industry.
ETST
US$0.09
7D
-1.3%
1Y
-56.1%
Aurinia Pharmaceuticals
Market Cap: US$2.1b
A biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan.
AUPH
US$15.29
7D
-1.0%
1Y
25.1%
Sotera Health
Market Cap: US$5.4b
Provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.
SHC
US$18.80
7D
-0.9%
1Y
19.0%
Rigel Pharmaceuticals
Market Cap: US$795.4m
A biotechnology company, develops and provides therapies that enhance the lives of patients with hematologic disorders and cancer in the United States.
RIGL
US$42.45
7D
1.9%
1Y
5.9%
TG Therapeutics
Market Cap: US$6.9b
A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.
TGTX
US$49.28
7D
0.2%
1Y
77.7%
Medpace Holdings
Market Cap: US$16.1b
Provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia.
MEDP
US$597.12
7D
-0.9%
1Y
29.0%
CapForce
Market Cap: US$46.4m
A precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally.
CFOR
US$4.00
7D
0%
1Y
3,999,900.0%